NCT02199899View on ClinicalTrials.gov

Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

July 31, 1999

Conditions
Healthy
Interventions
DRUG

BIIF 1149 BS - single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY